in treatment options and therapies are being made for a large number of
different types of cancers. Patients
who once considered themselves in the category of “guinea pigs” now view
themselves as “pioneers” as science is on the threshold of making major
breakthroughs with a whole range of new drug and treatment options for what was
once considered the most fatal of diseases.
as Gleevec and Mylotarg are now offering leukemia patients great hope as are
inhibitors of a protein known as FLT3 found in acute leukemia, and are now in
range of new drugs are currently in development that attack the metastic process
of the tumor by depriving the tumor of proteins that regulate the creation of
new blood vessels.
addition to angiogenesis inhibitor drugs (those that prevent the creation of new
blood vessels), monoclonal antibody therapy is being viewed as one of the most
promising areas of advancements currently being made.
The monoclonal antibodies attach to proteins on the surface of cancer
cells and interrupt the cell’s growth signals.
These drugs tend to have fewer side effects than traditional
more about recent developments that may pertain to the particular cancer type
you are interested in, go to: